Trial Profile
Single Center, Randomized, Open Labeled Pharmacokinetics Study of Azilsartan Tablets in Chinese Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Sep 2018
Price :
$35
*
At a glance
- Drugs Azilsartan (Primary)
- Indications Essential hypertension; Hypertension
- Focus Pharmacokinetics
- Sponsors Lee's Pharmaceutical
- 30 Aug 2018 Status changed to completed.
- 06 Jun 2016 New trial record